BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
32964420
Number of visits today
6548
Number of downloads
16126796
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Casati G, Giunti L, Iorio AL, Marturano A, Galli L, Sardi I. Hippo Pathway in Regulating Drug Resistance of Glioblastoma. IJMS 2021;22:13431. [DOI: 10.3390/ijms222413431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tu M, Zuo Z, Chen C, Zhang X, Wang S, Chen C, Sun Y. Transfer RNA-derived small RNAs (tsRNAs) sequencing revealed a differential expression landscape of tsRNAs between glioblastoma and low-grade glioma. Gene 2023;855:147114. [PMID: 36526122 DOI: 10.1016/j.gene.2022.147114] [Reference Citation Analysis]
2 Wang H, Min J, Liu J, Xu C, Liu Y, Yu Z, Gong A, Xu M. Hypoxia-elicited exosomes promote the chemoresistance of pancreatic cancer cells by transferring lncROR via Hippo signaling.. [DOI: 10.21203/rs.3.rs-2092052/v1] [Reference Citation Analysis]
3 Park J, Sim J, Ahn J, Kim YJ, Hwang S, Cho K, Chang DY, Jung JH, Moon JH, Sung K, Lim J. Molecular characteristics of incidental lower-grade glioma for treatment decision-making. J Neurosurg 2022;:1-10. [PMID: 35986732 DOI: 10.3171/2022.6.JNS22967] [Reference Citation Analysis]
4 Liang L, Yan B, Liu Y, Jiang S, He H, Huang J, Liu W, Xie L, Zhang Y. FOXP3 Contributes to TMZ Resistance, Prognosis, and Immune Infiltration in GBM from a Novel Pyroptosis-Associated Risk Signature. Disease Markers 2022;2022:1-21. [DOI: 10.1155/2022/4534080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Akhlaghdoust M, Tavakolpour S, Davoodi P, Rahmani S, Zali A, Rezaei N. Signaling Pathways in Neurological Cancers. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_14] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345